Martine A Rothblatt sold $4.1M of United Therapeutics (UTHR)

Executed Nov 4, disclosed Nov 5, 1 day later.

Value, as filed

$4.1M

6,792 sh across 14 lots

Executed

Nov 4

the trade date, as filed

Disclosed

Nov 5

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Martine A Rothblatt Chairperson & CEO profile →

Martine A Rothblatt (Chairperson & CEO) filed 187 Form 4 reports in the trailing twelve months (0 purchases, 187 sales, 1 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.9M of UTHR (18,840 sh across 15 lots, as filed), executed Apr 14.

The name

UTHR

United Therapeutics Corporation UTHR · Healthcare · 372 filings in 24 months ticker →

Healthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Martine A Rothblatt in UTHR

UTHRSALE United Therapeutics Corporation $946K
1,583 sh across 5 lots
Exec Nov 5
Filed Nov 6 · 4:57 PM ET UTHRSALE United Therapeutics Corporation $3.9M
6,744 sh across 17 lots
Exec Nov 5
Filed Nov 6 · 4:54 PM ET UTHRSALE United Therapeutics Corporation $1.0M
1,643 sh across 3 lots
Exec Nov 4
Filed Nov 5 · 5:21 PM ET UTHRSALE United Therapeutics Corporation $5.6M
9,380 sh across 7 lots
Exec Nov 3
Filed Nov 4 · 4:38 PM ET UTHRSALE United Therapeutics Corporation $5.7M
9,500 sh across 7 lots
Exec Nov 2
Filed Nov 3 · 4:30 PM ET UTHRSALE United Therapeutics Corporation $5.5M
9,221 sh across 9 lots
Exec Oct 30
Filed Nov 2 · 4:34 PM ET UTHRSALE United Therapeutics Corporation $5.6M
9,407 sh across 7 lots
Exec Oct 29
Filed Oct 30 · 4:30 PM ET UTHRSALE United Therapeutics Corporation $5.5M
9,420 sh across 5 lots
Exec Oct 28
Filed Oct 29 · 4:30 PM ET